PROPHARMACE HEALTHCARE LTD

PROPHARMACE HEALTHCARE LTD
Contents Page
For the Period 04 April 2024 to 30 June 2025

Statement of financial position	1
Notes to the financial statements	2

PROPHARMACE HEALTHCARE LTD
Statement of Financial Position
As at 30 June 2025

	Notes	2025 £
Fixed assets
Intangible fixed assets	3	501,467
		501,467
Current assets
Debtors		100
Net current assets		100

Total assets less current liabilities		501,567
Creditors: amount falling due after more than one year		(557,185)
Net assets		(55,618)

Capital and reserves
Called up share capital		100
Profit and loss account		(55,718)
Shareholders' funds		(55,618)

For the period ended 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The financial statements were approved by the board of directors on 01 January 2026 and were signed on its behalf by:

-------------------------------
Modar AL AHMAD
Director

1

PROPHARMACE HEALTHCARE LTD
Notes to the Abridged Financial Statements
For the Period 04 April 2024 to 30 June 2025

General Information

PROPHARMACE HEALTHCARE LTD is a private company, limited by shares, registered in England and Wales, registration number 15615525, registration address 47-49 PARK ROYAL ROAD, PREMIER BUSINESS CENTRE LONDON, NW10 7LQ.

The presentation currency is £ sterling.

1.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.

The financial statements are prepared in sterling which is the functional currency of the company.

Intangible assets

Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.

Goodwill
Acquired goodwill is stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the goodwill of 10 years.

2.	Average number of employees Average number of employees during the period was 0.

3.

Intangible fixed assets

Cost	Goodwill	Total
	£	£
At 04 April 2024	-	-
Additions	557,185	557,185
Disposals	-	-
At 30 June 2025	557,185	557,185
Amortisation
At 04 April 2024	-	-
Charge for period	55,718	55,718
On disposals	-	-
At 30 June 2025	55,718	55,718
Net book values
At 30 June 2025	501,467	501,467
At 03 April 2024	-	-

2

Registered Number: 15615525
England and Wales
PROPHARMACE HEALTHCARE LTD

Abridged Accounts

Period of accounts Start date: 04 April 2024 End date: 30 June 2025